+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
Healthy Volunteers
ID07385443

Development of a Comprehensive National Registry for Myotonic Dystrophy Type 1 in Spain Including Clinical, Genomic, Epigenomic, and Proteomic Data DM1-Hub

Led by Fundació Institut Germans Trias i Pujol · Updated on 2026-11-03

3000

Participants Needed

8

Research Sites

469 weeks

Total Duration

AI-Summary

What This Trial Is About

Myotonic Dystrophy Type 1 DM1 is a rare genetic neuromuscular disorder that varies widely in symptoms and affects multiple organs. It is the most common adult-onset muscular dystrophy, with an estimated prevalence of 1-5 per 10,000 people. In Spain, the condition shows regional differences, making it important to understand its characteristics within the population. This research aims to support a national initiative to better characterize DM1 by creating a comprehensive patient registry. The study is observational and involves collecting patient-reported information, clinical data, and omics data from individuals living in Spain who have a confirmed genetic diagnosis of DM1. Participants may be referred by healthcare providers or patient groups and, after consent, are connected with support staff for data collection. A control group without DM1 is also included to help identify biomarkers and improve understanding of disease prognosis. Participants will undergo follow-up assessments to track disease progression over time. Data collected include genomic and proteomic profiles, various physical and neurological tests, patient-reported outcomes related to quality of life and symptoms, and clinical measurements such as muscle strength and heart monitoring. The study is planned to continue through 2035, with the primary genomic characterization outcome measured at one year. Participant involvement includes clinical visits and data reporting to support ongoing research into DM1.

CONDITIONS

Brief Title

The Spanish National Registry for Myotonic Dystrophy Type 1

Research Team

G

Gisela Nogales Gadea, Ph.D.

A

Alvaro S Larran Mottino, Ph.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here